The Role of ElastPQ in Assessing Liver Stiffness for Non-Alcoholic Fatty Liver Disease in Patients Treated with Atypical Antipsychotic Drugs

• Published in: Neuropsychiatric disease and treatment Vol. 19; pp. 1491 - 1502
• Main Authors: Sun, Linlin, Li, Nan, Zhang, Ligang, Chen, Jingxu
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2023; Dove; Dove Medical Press
• Subjects: Antipsychotic drugs; antipsychotics drugs; Care and treatment; Complications and side effects; Diagnosis; Drug therapy; Drugs; elastography; Fatty liver; Liver diseases; Mental illness; Mentally ill; non-alcoholic fatty liver; Olanzapine; Original Research; Patient outcomes; Type 2 diabetes; ultrasound; China; elastography; non-alcoholic fatty liver; antipsychotics drugs; ultrasound

To evaluate the role of elastography point quantification (ElastPQ) for the quantitative assessment of stiffness in the fatty liver disease in mental disorder patients and to provide a noninvasive detection method for non-alcoholic fatty liver (NAFLD) caused by atypical antipsychotics drugs (AAPDs)....